Repetitive injections of growth hormone releasing hormone (GHRH1-44) to normal volunteers and patients with growth hormone deficiency
- PMID: 2182500
- DOI: 10.1055/s-2007-1004860
Repetitive injections of growth hormone releasing hormone (GHRH1-44) to normal volunteers and patients with growth hormone deficiency
Abstract
The present study was designed to answer the following three questions: Is there any difference between the growth hormone (GH) response to i.v. injections of GHRH 1-44 by a slowly injecting hormone pump or to a s. s. or rapid i. v. injection by syringe? Do nocturnal injections of GHRH 1-44 i. v. elicit different GH levels than during daytime? Can repetitive administration of GHRH 1-44 in patient with GH deficiency induce a physiological GH pattern and thereby normalize the condition resulting from a hypothalamic defect? A rapid i. v. bolus injection of 50 micrograms GHRH 1-44 by syringe with an injection time of one second elicited in the same subject at the same time of the day a twofold greater response than a slowly injecting (60 seconds) hormone pump. In six male adult volunteers each GHRH i. v. bolus was followed by a GH secretory pulse. The GH response at night (area under the curve and peak plasma GH levels) was significantly greater than at daytime (P less than 0.05) and greater than the GH pulses measured during a spontaneous nocturnal profile (P less than 0.05). Out of six GH deficient young adult patients who had been receiving extractive GH until two years prior to the study, three responded much like the controls, the other three patients-those who lacked any spontaneous nocturnal GH peaks-had markedly lower GH levels after GHRH (P less than 0.05). However, there was a clear-cut GH release after GHRH injection in each patient.(ABSTRACT TRUNCATED AT 250 WORDS)
Comment in
-
Repetitive injections of GHRH in normal children and adults.Horm Metab Res. 1990 Sep;22(9):510. doi: 10.1055/s-2007-1004959. Horm Metab Res. 1990. PMID: 2258141 No abstract available.
Similar articles
-
Nocturnal augmentation of growth hormone (GH) secretion is preserved during repetitive bolus administration of GH-releasing hormone: potential involvement of endogenous somatostatin--a clinical research center study.J Clin Endocrinol Metab. 1995 Nov;80(11):3321-6. doi: 10.1210/jcem.80.11.7593445. J Clin Endocrinol Metab. 1995. PMID: 7593445 Clinical Trial.
-
Longtime administration of growth hormone-releasing hormone (GHRH) does not restore the reduced efficiency of GHRH on sleep endocrine activity in 2 old-aged subjects--a preliminary study.Pharmacopsychiatry. 1997 Jul;30(4):122-4. doi: 10.1055/s-2007-979496. Pharmacopsychiatry. 1997. PMID: 9271777 Clinical Trial.
-
Effects of dexamethasone on growth hormone (GH)-releasing hormone, arginine- and dopaminergic stimulated GH secretion, and total plasma insulin-like growth factor-I concentrations in normal male volunteers.J Clin Endocrinol Metab. 1991 Mar;72(3):675-81. doi: 10.1210/jcem-72-3-675. J Clin Endocrinol Metab. 1991. PMID: 1671785
-
[Growth hormone releasing hormone. Review].Klin Padiatr. 1988 Mar-Apr;200(2):81-8. doi: 10.1055/s-2008-1033691. Klin Padiatr. 1988. PMID: 3133522 Review. German.
-
Long-acting forms of growth hormone-releasing hormone and growth hormone: effects in normal volunteers and adults with growth hormone deficiency.Horm Res. 2007;68 Suppl 5:178-81. doi: 10.1159/000110620. Epub 2007 Dec 10. Horm Res. 2007. PMID: 18174751 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources